To further assess the clinical significance of FTO-SIK2-autophagy axis promoting ccRCC progression, we examined the expression of FTO and SIK2 in tumor tissues of patients with ccRCC and subsequently categorized the samples into FTO-low and FTO-high groups and determined their relevance in ccRCC. The gene discussed is SIK2; the disease is neoplasm.